seRNA – enter the next level of mRNA technology

seRNA – enter the next level of mRNA technology

Specific
Universal
Revolutionary
Fast
Specific
Universal
Revolutionary
Fast

We are developing the first pro-drug platform on RNA level, targeting oncological, viral and further non-oncological diseases

It is our mission to open a new chapter in treating diseases and to deliver so called selectively expressed RNAs (seRNAs) to patients. We have an ambitious pipeline that targets indications of highest medical need. Many devastating diseases cannot be effectively treated. Even if therapies exist, often they don’t specifically target the diseased area, leading to a high risk of severe side effects. To overcome this inherent problem, we have developed seRNA as a new RNA-based therapy approach.

seRNAs are combining the best of 3 worlds

RNAi interference

for cell specific targeting

mRNA

for cell functionalization via expression of the effector molecule

Proprietary fLNPs

for organ-specific pre-targeting and delivery

RNAi interference

for cell specific targeting

mRNA

for cell functionalization via expression of the effector molecule

Proprietary fLNPs

for organ-specific pre-targeting and delivery

Writing a new chapter in treating diseases

We want to deliver more specific and effective treatments in the following areas:

Oncology

Oncology

With primary liver cancer (HCC) and Glioblastoma we are treating two diseases of highest medical need based on systemically and locally applied seRNAs, respectively. For both, animal data have already proven extraordinary effectiveness and biocompatibility of seRNA-based treatments. Lung cancer as seRNA target is our third pipeline project with high medical need.

Autoimmune diseases

Autoimmune diseases

Immune cells present highly specialized surface markers on their respective surfaces and thus also provide specific sequences on the RNA level that can be used for the targeted activation of seRNA constructs to treat epitope-specific disorders.

Our commitment

We are committed to opening a new chapter in treating diseases & bringing seRNAs to patients. seRNAs are a specific, fast, universal and revolutionary new treatment modality. We are getting more excited by seRNAs every day and will not rest until we have developed seRNAs to their full potential.